Galectin-3 as Damage-Sensor Scaffold for Multimeric Cross-Seeding at Compromised Endo/Lysosomal Membranes

Target: LGALS3 Composite Score: 0.455 Price: $0.52▲5.2% Citation Quality: Pending neurodegeneration Status: active
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
⚠ Low Validation Senate Quality Gates →
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
3
Opposing
Quality Report Card click to collapse
C
Composite: 0.455
Top 73% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 76%
C+ Evidence Strength 15% 0.50 Top 57%
C+ Novelty 12% 0.50 Top 82%
C+ Feasibility 12% 0.50 Top 65%
F Impact 12% 0.00 Top 50%
C+ Druggability 10% 0.50 Top 57%
C+ Safety Profile 8% 0.50 Top 57%
C+ Competition 6% 0.50 Top 77%
C+ Data Availability 5% 0.50 Top 71%
C+ Reproducibility 5% 0.50 Top 63%
Evidence
5 supporting | 3 opposing
Citation quality: 0%
Debates
2 sessions B
Avg quality: 0.61
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

Protein aggregation cross-seeding across neurodegenerative diseases

Protein aggregation cross-seeding across neurodegenerative diseases?

→ View full analysis & debate transcript

Description

Galectin-3's carbohydrate recognition domain binds exposed glycans on ruptured endolysosomal membranes while its intrinsically disordered N-terminus provides a phase-separated condensation surface that recruits aggregation-prone proteins (Aβ42, α-synuclein, TDP-43) into localized high-concentration environments favoring cross-nucleation.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Endolysosomal Membrane Rupture
Amyloid or Oxidative Stress"] B["Luminal Glycan Exposure
beta-galactose on Damaged Membranes"] C["LGALS3 Galectin-3 CRD Domain
Carbohydrate Recognition Domain Binds"] D["LGALS3 N-Terminal IDR
Intrinsically Disordered Phase-Sep Region"] E["Phase-Separated Condensate
Galectin-3 Scaffold at Rupture Site"] F["Aggregation-Prone Protein Concentration
Cross-Seeding Opportunity"] G["Tau SNCA TDP43 FUS Recruitment
Multi-Protein Cross-Seeding"] H["Multimeric Amyloid Propagation
Endolysosomal Rupture Amplified"] A --> B B --> C C --> D D --> E E --> F F --> G G --> H style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8 style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
8 citations 8 with PMID 8 medium Validation: 0% 5 supporting / 3 opposing
For (5)
5
3
(3) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
5
1
MECH 2CLIN 5GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
ALS-linked mutant TDP-43 in oligodendrocytes induc…SupportingCLINActa Neuropatho… MEDIUM2024-PMID:39605053-
ALS-associated TDP-43 aggregates drive innate and …SupportingGENEiScience MEDIUM2025-PMID:40520109-
Towards a TDP-43-Based Biomarker for ALS and FTLD.SupportingCLINMol Neurobiol MEDIUM2018-PMID:29460270-
TDP-43 toxic gain of function links ALS, FTD and A…SupportingMECHbioRxiv MEDIUM2025-PMID:40654715-
Sephin1 reduces TDP-43 cytoplasmic mislocalization…SupportingCLINLife Sci Allian… MEDIUM2025-PMID:40602832-
Organelle-specific autophagy in inflammatory disea…OpposingCLINAutophagy MEDIUM2021-PMID:32048886-
Mesenchymal Stem Cell-Derived Exosomes as New Reme…OpposingCLINInt J Mol Sci MEDIUM2021-PMID:33535376-
Wallerian degeneration: the innate-immune response…OpposingMECHJ Neuroinflamma… MEDIUM2011-PMID:21878125-
Legacy Card View — expandable citation cards

Supporting Evidence 5

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction … MEDIUM
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice.
Acta Neuropathol Commun · 2024 · PMID:39605053
ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation. MEDIUM
iScience · 2025 · PMID:40520109
Towards a TDP-43-Based Biomarker for ALS and FTLD. MEDIUM
Mol Neurobiol · 2018 · PMID:29460270
TDP-43 toxic gain of function links ALS, FTD and Alzheimer's Disease through splicing dysregulation. MEDIUM
bioRxiv · 2025 · PMID:40654715
Sephin1 reduces TDP-43 cytoplasmic mislocalization and improves motor neuron survival in ALS models. MEDIUM
Life Sci Alliance · 2025 · PMID:40602832

Opposing Evidence 3

Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality c… MEDIUM
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Autophagy · 2021 · PMID:32048886
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders. MEDIUM
Int J Mol Sci · 2021 · PMID:33535376
Wallerian degeneration: the innate-immune response to traumatic nerve injury. MEDIUM
J Neuroinflammation · 2011 · PMID:21878125
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-12 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Mechanistically Novel Hypotheses: Protein Aggregation Cross-Seeding in Neurodegeneration

Hypothesis 1: Galectin-3 as a Universal Sensor-Dependent Cross-Seeding Platform at Damaged Endo/Lysosomal Membranes

Mechanism


Galectin-3 (LGALS3) functions as a "damage scaffold" that simultaneously recruits multiple aggregation-prone proteins (Aβ42, α-synuclein, TDP-43) to ruptured endolysosomal membranes, creating a localized high-concentration environment that favors cross-nucleation. The galectin carbohydrate recognition domain recognizes exposed glycans on damaged organelle membranes

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation: Protein Aggregation Cross-Seeding Hypotheses

Hypothesis 1: Galectin-3 as a Universal Sensor-Dependent Cross-Seeding Platform

1. Strongest Specific Weakness: The Mechanism Conflates Co-Localization with Catalytic Cross-Seeding Activity

The proposal argues that galectin-3 simultaneously recruits Aβ42, α-synuclein, and TDP-43 to damaged endolysosomal membranes, creating a high-concentration environment that favors cross-nucleation. However, the cited evidence demonstrates only co-localization, not catalysis. Galectin-3 is a lectin with established carbohy

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Domain Expert Assessment: Cross-Seeding Hypotheses in Neurodegeneration

Preliminary Note on Hypothesis Characterization

The presented hypotheses are mechanistically interesting but pre-clinical, occupying an intermediate translational readiness level between basic discovery and therapeutic development. The galectin-3 proposal in particular represents a sophisticated speculation that requires significant experimental derisking before reaching IND-enabling studies. I will therefore evaluate translational potential not against an abstract standard, but against what is achievable

Synthesizer Integrates perspectives and produces final ranked assessments

{"ranked_hypotheses":[{"rank":1,"title":"Galectin-3 as Damage-Sensor Scaffold for Multimeric Cross-Seeding at Compromised Endo/Lysosomal Membranes","mechanism":"Galectin-3's carbohydrate recognition domain binds exposed glycans on ruptured endolysosomal membranes while its intrinsically disordered N-terminus provides a phase-separated condensation surface that recruits aggregation-prone proteins (Aβ42, α-synuclein, TDP-43) into localized high-concentration environments favoring cross-nucleation.","target_gene":"LGALS3","confidence_score":0.55,"novelty_score":0.75,"feasibility_score":0.40,"im

Price History

0.460.490.51 0.54 0.43 2026-04-212026-04-252026-04-28 Market PriceScoreevidencedebate 8 events
7d Trend
Stable
7d Momentum
▲ 6.6%
Volatility
High
0.0509
Events (7d)
7

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (8)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.505

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for LGALS3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for LGALS3 →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

KG Entities (33)

DNAJB6G3BP1HSPG2LGALS3 (galectin-3)LGALS3 deficiencyLGALS3 upregulationPHB2RNA granule phase separationTARDBPTAUTDP-43 pathologyTDP43TGM2TREM2amyloid clearanceamyloid nucleationamyloid plaque pathologycellular stresscognitive decline in Alzheimer's patientcross-disease protein aggregation risk

Related Hypotheses

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysosomal membrane permeabilization
Score: 0.625 | neuroscience
Lectin-Mediated Autophagy Enhancers
Score: 0.455 | neurodegeneration
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.907 | neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 | neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (49 edges)

causes (2)

cellular stressLGALS3 upregulationTDP-43 pathologycognitive decline in Alzheimer's patients

co associated with (10)

HSPG2TARDBPHSPG2PHB2DNAJB6HSPG2DNAJB6PHB2PHB2TARDBP
▸ Show 5 more

co discussed (25)

TREM2HSPG2TREM2G3BP1TREM2TARDBPTREM2TGM2HSPG2G3BP1
▸ Show 20 more

enables (2)

endolysosomal membrane damagecross-seeding of aggregation-prone proteinsRNA granule phase separationtransient cross-seeding hub formation

increases (2)

traumatic brain injurycross-disease protein aggregation riskviral infectionscross-disease protein aggregation risk

inhibits (1)

steric zipper hexapeptide inhibitorscross-seeding between amyloidogenic proteins

modulates (1)

specific lipid perturbationscross-seeding specificity

prevents (1)

LGALS3 deficiencyamyloid plaque pathology

promotes (5)

LGALS3 (galectin-3)cross-nucleation at damaged endolysosomal membranesLGALS3 (galectin-3)amyloid plaque pathologyLGALS3 (galectin-3)lysosomal quality controlsteric zipper motifsamyloid nucleationlecanemab/donanemabamyloid clearance

Mechanism Pathway for LGALS3

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    LGALS3__galectin_3_["LGALS3 (galectin-3)"] -->|promotes| lysosomal_quality_control["lysosomal quality control"]
    cellular_stress["cellular stress"] -->|causes| LGALS3_upregulation["LGALS3 upregulation"]
    LGALS3__galectin_3__1["LGALS3 (galectin-3)"] -->|promotes| cross_nucleation_at_damag["cross-nucleation at damaged endolysosomal membranes"]
    LGALS3__galectin_3__2["LGALS3 (galectin-3)"] -->|promotes| amyloid_plaque_pathology["amyloid plaque pathology"]
    LGALS3_deficiency["LGALS3 deficiency"] -->|prevents| amyloid_plaque_pathology_3["amyloid plaque pathology"]
    style LGALS3__galectin_3_ fill:#4fc3f7,stroke:#333,color:#000
    style lysosomal_quality_control fill:#4fc3f7,stroke:#333,color:#000
    style cellular_stress fill:#4fc3f7,stroke:#333,color:#000
    style LGALS3_upregulation fill:#4fc3f7,stroke:#333,color:#000
    style LGALS3__galectin_3__1 fill:#4fc3f7,stroke:#333,color:#000
    style cross_nucleation_at_damag fill:#4fc3f7,stroke:#333,color:#000
    style LGALS3__galectin_3__2 fill:#4fc3f7,stroke:#333,color:#000
    style amyloid_plaque_pathology fill:#ef5350,stroke:#333,color:#000
    style LGALS3_deficiency fill:#ce93d8,stroke:#333,color:#000
    style amyloid_plaque_pathology_3 fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 LGALS3 — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for LGALS3 structures...
Querying Protein Data Bank API

Source Analysis

Protein aggregation cross-seeding across neurodegenerative diseases

neurodegeneration | 2026-04-01 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (2)

Membrane Lipid Composition-Dependent Specificity Switch Enabling Cross
Score: 0.46 · PLD3
RNA Granule Phase Separation as Transient Cross-Seeding Hub
Score: 0.46 · TARDBP
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.